about
Association Between Prognosis and Tumor Laterality in Early-Stage Colon Cancer.Chemotherapy for resected colorectal cancer pulmonary metastases: Utilization and outcomes in routine clinical practice.Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population.Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data.Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers.Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers.Concurrent chemoradiotherapy for bladder cancer: Practice patterns and outcomes in the general population.Peri-operative blood transfusion for resected colon cancer: Practice patterns and outcomes in a population-based study.Temporal trends in management and outcomes of testicular cancer: A population-based study.Variation in routine follow-up care after curative treatment for head-and-neck cancer: a population-based study in Ontario.Venous Thromboembolism and Peri-Operative Chemotherapy for Muscle-Invasive Bladder Cancer: A Population-based StudySalivary secretory immunoglobulin A reactivity: a comparison to cortisol and α-amylase patterns in the same breast cancer survivorsPulmonary Metastasectomy for Colorectal Cancer: Predictors of Survival in Routine Surgical PracticeDisease Characteristics, Clinical Management, and Outcomes of Young Patients With Colon Cancer: A Population-based StudyDelivery of Pediatric Cancer Care in Mexico: A National SurveyRoutine follow-up care after curative treatment of head and neck cancer: A survey of patients' needs and preferences for healthcare services
P50
Q38736285-32D40E6B-BFD2-479A-A066-92EE4AB07936Q40152222-A73FC8EC-D6EE-4D45-8537-05DC3BB541FAQ40271928-09AF5393-F852-4E21-8768-509EB3D124EFQ47287526-83064B11-4F26-4DB9-BDAD-5843D44BD777Q47317579-D530F529-2072-4A35-BEE7-E0670F4554F6Q47667966-CB45F791-0E00-4572-9F1C-077651597564Q49398793-156FA516-3828-4A2F-8EAD-A7783C6C5695Q50117386-B9FEC0A3-59F4-4820-862B-4827E111A290Q50462792-95A1C520-8CB0-4818-913B-AC5A83665BB3Q52719029-652C4B2D-C451-402A-87EA-CFE2CCE7F13AQ55166764-D9FD5D57-04A1-45CA-AC9B-ED08AC5B77D0Q58705150-911F8827-FC83-4BE4-A80B-CF68B61A0CD5Q59129070-5E42A982-6E12-4718-AA4B-32FA6827FEFFQ88003554-39F5D513-8C1B-41FF-9139-9E2CA0257A1FQ90643521-5FBD0FEF-A7E1-4C64-8F64-6DA7EA0A2B21Q90803935-6409734B-3BFA-43FA-B3F1-C8661FC9974DQ91105532-A32FFC07-6C22-45B3-9E82-9EA9C18AFDEA
P50
description
researcher ORCID ID = 0000-0002-3498-2634
@en
wetenschapper
@nl
name
Kelly Brennan
@ast
Kelly Brennan
@en
Kelly Brennan
@es
Kelly Brennan
@nl
type
label
Kelly Brennan
@ast
Kelly Brennan
@en
Kelly Brennan
@es
Kelly Brennan
@nl
prefLabel
Kelly Brennan
@ast
Kelly Brennan
@en
Kelly Brennan
@es
Kelly Brennan
@nl
P1153
57193872191
P31
P496
0000-0002-3498-2634